Trustmark National Bank Trust Department Has $2.25 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Trustmark National Bank Trust Department lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 89.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,844 shares of the healthcare conglomerate's stock after purchasing an additional 1,816 shares during the period. Trustmark National Bank Trust Department's holdings in UnitedHealth Group were worth $2,248,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Delta Financial Group Inc. lifted its stake in UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate's stock valued at $965,000 after acquiring an additional 17 shares in the last quarter. Signature Resources Capital Management LLC raised its holdings in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock worth $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 3.5% in the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate's stock worth $270,000 after buying an additional 18 shares in the last quarter. GoalVest Advisory LLC grew its stake in UnitedHealth Group by 0.6% in the 2nd quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate's stock worth $1,591,000 after buying an additional 18 shares in the last quarter. Finally, Fiduciary Group LLC raised its holdings in shares of UnitedHealth Group by 0.5% during the 2nd quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate's stock valued at $1,882,000 after buying an additional 18 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Stephens cut their price objective on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research note on Wednesday, October 16th. Cantor Fitzgerald raised their price target on UnitedHealth Group from $591.00 to $644.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 16th. StockNews.com lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Wednesday. Finally, KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They set an "overweight" rating and a $675.00 target price for the company. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $615.53.

UnitedHealth Group Trading Up 4.1 %

UnitedHealth Group stock opened at $600.50 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $552.63 billion, a price-to-earnings ratio of 39.12, a price-to-earnings-growth ratio of 1.69 and a beta of 0.58. The business has a 50 day moving average price of $582.52 and a two-hundred day moving average price of $551.60.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion during the quarter, compared to analysts' expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. UnitedHealth Group's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business earned $6.56 EPS. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group's payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.